Cargando…
Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro
AIM OF THE STUDY: To evaluate the frequency of MRE11/RAD50/NBS1 (MRN)-complex loss of protein expression in endometrial cancers (EC) and to determine whether loss of MRE11 renders the cancer cells sensitive to Poly(ADP-ribose) polymerase (PARP)-inhibitory treatment. METHODS: MRN expression was exami...
Autores principales: | Koppensteiner, Romana, Samartzis, Eleftherios P., Noske, Aurelia, von Teichman, Adriana, Dedes, Ioannis, Gwerder, Myriam, Imesch, Patrick, Ikenberg, Kristian, Moch, Holger, Fink, Daniel, Stucki, Manuel, Dedes, Konstantin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057395/ https://www.ncbi.nlm.nih.gov/pubmed/24927325 http://dx.doi.org/10.1371/journal.pone.0100041 |
Ejemplares similares
-
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer
por: Brandt, Simone, et al.
Publicado: (2017) -
ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
por: Samartzis, Eleftherios P., et al.
Publicado: (2013) -
Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study
por: Samartzis, Nicolas, et al.
Publicado: (2012) -
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
por: Samartzis, Eleftherios P, et al.
Publicado: (2014) -
Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report
por: Valtcheva, Nadejda, et al.
Publicado: (2017)